Role of blood rheology in the pathogenesis of hypertension of hemodialysis patients treated for renal anemia with recombinant human erythropoietin

Contrib Nephrol. 1990:82:79-85. doi: 10.1159/000418721.
No abstract available

MeSH terms

  • Anemia / complications*
  • Anemia / etiology
  • Anemia / therapy
  • Blood Pressure / physiology
  • Blood Viscosity / physiology*
  • Erythropoietin / adverse effects
  • Erythropoietin / therapeutic use*
  • Hematocrit
  • Humans
  • Hypertension / blood*
  • Hypertension / etiology
  • Kidney Failure, Chronic / complications
  • Kidney Failure, Chronic / therapy
  • Recombinant Proteins / adverse effects
  • Recombinant Proteins / therapeutic use
  • Renal Dialysis / adverse effects*

Substances

  • Recombinant Proteins
  • Erythropoietin